Cited by 888Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.

Diabetic dyslipidaemia: from basic research to clinical practice*

Open access

Taskinen, M.-R.·2003·Diabetologia

DOI 10.1007/s00125-003-1111-y

Open this paper in CoChat — free account Open PDF

Abstract

The recognition that the increase of plasma triglyceride rich lipoproteins (TRLs) is associated with multiple alterations of other lipoproteins species that are potentially atherogenic has expanded the picture of diabetic dyslipidaemia. The discovery of heterogeneity within major lipoprotein classes VLDL, LDL and HDL opened new avenues to reveal the specific pertubations of diabetic dyslipidaemia. The increase of large VLDL 1 particles in Type 2 diabetes initiates a sequence of events that generates atherogenic remnants, small dense LDL and small dense HDL particles. Together these components comprise the atherogenic lipid triad. Notably the malignant nature of diabetic dyslipidaemia is not completely shown by the lipid measures used in clinical practice. The key question is what are the mechanisms behind the increase of VLDL 1 particles in diabetic dyslipidaemia? Despite the advances of recent years, our understanding of VLDL assembly and secretion is still surprisingly incomplete. To date it is still unclear how the liver is able to regulate the amount of triglycerides incorporated into VLDL particles to produce either VLDL 1 or VLDL 2 particles. The current evidence suggests that the machinery driving VLDL assembly in the liver includes (i) low insulin signalling via PI-3 kinase pathway that enhances lipid accumulation into "nascent " VLDL particles (ii) up-regulation of SREBP-1C that stimulates de novo lipogenesis and (iii) excess availability of "polar molecules" in hepatocytes that stabilizes apo B 100. Recent data suggest that all these steps could be fundamentally altered in Type 2 diabetes explaining the overproduction of VLDL apo B as well as the ability of insulin to suppress VLDL 1 apo B production in Type 2 diabetes. Recent discoveries have established the transcription factors including PPARs, SREBP-1 and LXRs as the key regulators of lipid assembly in the liver. These observations suggest these factors as a new target to tailor more efficient drugs to treat diabetic dyslipidaemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-003-1111-y

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Self-citation
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014

Show all 183 references

Sorted by citations

Items 601–700 of 885

Combined untargeted and targeted lipidomics approaches reveal potential biomarkers in type 2 diabetes mellitus cynomolgus monkeys
Tian, C., Yang, Q., Lv, H., Yue, F., & Zhou, F. (2023) · Journal of Medical Primatology · doi:10.1111/jmp.12688 · Cited by 4
Hallmarks of diabetes mellitus and insights into the therapeutic potential of synergy-based combinations of phytochemicals in reducing oxidative stress-induced diabetic complications
Dar, M. I., Gulya, A., Abass, S., Dev, K., Parveen, R., Ahmad, S., & Qureshi, M. I. (2024) · Natural Product Research · doi:10.1080/14786419.2024.2402461 · Cited by 4
Machine learning-driven Raman spectroscopy: A novel approach to lipid profiling in diabetic kidney disease
Kryska, A., Sawic, M., Depciuch, J., Sosnowski, P., Szałaj, K., Paja, W., Khalavka, M., & Sroka‐Bartnicka, A. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102804 · Cited by 4
Is There a Relation Between Triglyceride Concentrations in Very Low Density Lipoprotein and the Index of Insulin Resistance in Nondiabetic Subjects?
Kurosaki, Y., Tsukushi, T., Munekata, S., Kanoh, Y., Moriya, T., Nishinari, M., Aoyama, N., & Ogawa, Z. (2014) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21677 · Cited by 4
Familial hypobetalipoproteinemia due to a novel early stop mutation
Durrington, P. N., Charlton-Menys, V., Packard, C. J., CASLAKE, M. J., Wang, J., Bhatnagar, D., Scott, J., & Hegele, R. A. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.08.446 · Cited by 4
Saroglitazar: India's Answer to Diabetic Dyslipidemia
Aggarwal, A. (2014) · International Journal of Pharmacology and Clinical Sciences · Cited by 4
Dyslipidemia in Obesity
Chan, D. C., Pang, J., & Watts, G. F. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_30-1 · Cited by 5
Managing Cardiovascular Complications in Diabetes
Betteridge, J. D., & Nicholls, S. J. (2014) · Wiley eBooks · doi:10.1002/9781118337967 · Cited by 5
Magnetic resonance imaging for acute pancreatitis in type 2 diabetes patients
Ni, Y.-H., Song, L.-J., & Xiao, B. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i30.7268 · Cited by 4
Reduction in Secretion of Very Low Density Lipoprotein–Triacylglycerol by a Matrix Metalloproteinase Inhibitor in a Rat Model of Diet-Induced Hypertriglyceridemia
Kawashima, Y., Eguchi, Y., Yamazaki, T., Karahashi, M., Kawai, H. F., & Kudo, N. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.246165 · Cited by 4
Purple Rice Bran Improves Hepatic Insulin Signaling via Activation of Akt and Stabilization of IGF in Diabetic Rats
Hlaing, E. E., Rungcharoenarrichit, S., Lailerd, N., Roytrakul, S., & Piamrojanaphat, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814466-4.00025-2 · Cited by 4
Relationship between Lipid Indices, Type IV Collagen Turnover and the Development of Microvascular Complications in Diabetic Patients with Arterial Hypertension
NIKOLOV, A. G., Tzekova, M., & Blazhev, A. B. (2019) · Folia Medica · doi:10.2478/folmed-2018-0072 · Cited by 4
Differential risk factors and morbidity/mortality pattern in type 2 diabetes: A study among two Mendelian populations with different ancestry (India)
Longkumer, I., Devi, N. K., Murry, B., & Saraswathy, K. N. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.09.006 · Cited by 4
Alterations in the transfer of phospholipids from very-low density lipoproteins to activated platelets in type 2 diabetes
Ibrahim, S. A., Guillot, N., Pruneta‐Deloche, V., Charrière, S., Calzada, C., Guichardant, M., Moulin, P., Lagarde, M., & Ponsin, G. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.045 · Cited by 4
The role of postprandial hyperglycemia and hyperlipidemia in CVD risk
Heine, R. J. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0043-6 · Cited by 4
Oxidative Stress in Mongoloids and Caucasians with Type 1 Diabetes
Kolesnikova, L. I. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000376 · Cited by 4
Assembly and Secretion of Atherogenic Lipoproteins
Adiels, C. B. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 4
Associations of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with diabetes and prediabetes among adults with hypertension: a cross-sectional study
Meng, Q., Fan, S., Zhang, L., Shen, B., Zou, C., Sun, D., Liu, X., Zhang, J., & Xu, S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1523016 · Cited by 3
Synthesis and In Vitro/In Silico α-Glucosidase Inhibitory Study of Novel Ethanones Containing Naphthalene-Linked 1,2,4-Triazole
Nguyen, C. T., Hoang, D. T. K., Truong, V. A., Nguyen, L. T., Dinh, P. C., Mai, D. H. A., Le, T. D., & Pham, N. N. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00387 · Cited by 3
Treatment of Dyslipidemia in Patients with Type 1 Diabetes Mellitus: A Review of Current Evidence and Knowledge Gaps
Elian, V., Dorita, A., Stegaru, D., & Vinereanu, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178558 · Cited by 4
Relationship of Plasma Apolipoprotein C-I Truncation With Risk of Diabetes in the Multi-Ethnic Study of Atherosclerosis and the Actos Now for the Prevention of Diabetes Study
Koška, J., Hu, Y., Furtado, J. D., Billheimer, D. D., Nedelkov, D., Schwenke, D. C., Budoff, M. J., Bertoni, A. G., McClelland, R. L., & Reaven, P. D. (2024) · Diabetes Care · doi:10.2337/dc24-1462 · Cited by 3
Effects of Cirsium japonicum var. maackii on avelliation of metabolic disease by improving insulin resistance
Yoon, H.-B., Jang, Y., Paik, H.-G., Choi, H., Choi, J.-H., & Kwon, J. (2025) · Laboratory Animal Research · doi:10.1186/s42826-025-00234-w · Cited by 3
Exploring the benefits of alirocumab as lipid-lowering therapy in people with diabetes and very high cardiovascular risk
Avogaro, A., Buzzetti, R., Candido, R., Cosmo, S. D., Notarianni, L., Consolo, E., & Luciano, M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112055 · Cited by 3
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and hyperuricemia: evidence from the CHARLS study
Hou, X., Zhu, Z., Chen, X., Li, Y., Feng, G., Zhou, X., Gong, Z., Yang, Y., & Zhang, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1552184 · Cited by 4
Residual cholesterol is an independent risk factor for new-onset hyperuricemia: a nationwide cohort study based on a middle-aged and elderly population
Zhang, J., Hao, Z., Ma, Y., Zheng, P., Huang, L. J., Xu, J., & Wang, J. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104118 · Cited by 3
Assessment of the relationship between insulin resistance, atherogenic index of plasma and white blood cell count: A data mining study
Doğan, H. O. (2017) · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · doi:10.7197/223.v39i29491.316368 · Cited by 3
Association between postprandial lipoprotein subclasses and Framingham cardiovascular disease risk stratification
Gu, C., Wang, N., Ren, P., Wu, X., Pang, B., Zhang, S., Hou, X., Xu, D., Yuan, Y., & Liu, G. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.12.009 · Cited by 4
Effect of Photoconductivity Precursor Volume on Structural, Physical, Electrical and Optical Properties of Thin Layers of Cadmium Oxide (CdO) Nanostructures Produced Using Spray Pyrolysis Technique
Alireza, H. (2021) · International Journal of Membrane Science and Technology · doi:10.15379/2410-1869.2021.08.02.04 · Cited by 3
Clove (Syzygium aromaticum) volatiles
Charoonratana, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85177-0.00022-7 · Cited by 3
Lipid Profile and Small Dense Low-Density Lipoprotein in Acute Coronary Syndrome Patients: Relationships to Demographic, Clinical, Angiographic, and Therapeutic Variables
Pradhan, A. K., Kuka, R., Vishwakarma, P., Ali, W., Perrone, M. A., Iellamo, F., Chaudhary, G. K., Chandra, S., Sethi, R., Dwivedi, S. K., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226846 · Cited by 3
Role of LDL and Triglycerides in Hyperlipidemia in Diabetes Mellitus
Bethelli, S., & Oroszi, T. L. (2023) · Journal of Family Medicine and Disease Prevention · doi:10.23937/2469-5793/1510155 · Cited by 3
An Intelligent Diabetes Prediction System Augmenting Feature Selection and Balancing Techniques
Giri, S. K., Dash, S., & Sahoo, T. (2024) · Lecture notes in networks and systems · doi:10.1007/978-981-99-5015-7_9 · Cited by 3
Hyperlipidémie des diabétiques
Vergés, B. (2004) · EMC - Endocrinologie - Nutrition · doi:10.1016/j.emcend.2004.02.001 · Cited by 1
Metabolic effects of the consumption of aqueous Kalanchoe pinnata preparation in streptozotocin-induced diabetic rats
Menon, N. (2014) · Cited by 3
Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease
Zaman, H. (2012) · InTech eBooks · doi:10.5772/29383 · Cited by 3
Type 2 Diabetes Mellitus and Dyslipidemia
Cederberg, H., & Laakso, M. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_6 · Cited by 3
CETP, a key player in atherogenic dyslipidemia of Type II diabetes
Chapman, J., & Guérin, M. (2004) · International Congress Series · doi:10.1016/j.ics.2003.12.108 · Cited by 3
Re-Visiting Glutamate Toxicity: Implications of Monosodium Glutamate Consumption on Glutamate Metabolism and Metabolic Syndrome
Day, P. E., Matata, B. M., & Elahic, M. (2015) · Journal of Endocrinology and Diabetes Mellitus · doi:10.12970/2310-9971.2015.03.01.5 · Cited by 3
Serum lipid profile and glycated hemoglobin status in Omani patientswith type2 diabetes mellitus attending a primary care polyclinic.
Alalawi, S. (2014) · Biomedical Research-tokyo · Cited by 3
Measuring VLDL1-Triglyceride and VLDL2-Triglyceride Kinetics in Men: Effects of Dietary Control on Day-to-Day Variability
Johansen, R. F., Søndergaard, E., Sørensen, L., Jurik, A. G., & Nielsen, S. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-109561 · Cited by 3
An up-to-date evaluation of alogliptin benzoate for the treatment of type 2 diabetes
Hu, J., Yang, C., Wang, H., Li, J., Tan, X., Wang, J., Zhang, B., & Zhao, Y. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1645124 · Cited by 3
Production and Metabolism of Triglyceride-Rich Lipoproteins in Both the Normal and Diabetic States
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_6 · Cited by 3
Optimizing nicotinic acid delivery for durable antilipolysis and improved metabolic control
Kroon, T. (2016) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences)) · Cited by 3
Biochemical Profile Variations Among Type 2 Diabetic Patients Stratified by Hemoglobin A1c Levels in a Saudi Cohort: A Retrospective Study
Alshalani, A., Alahmari, N., Amin, H. A., Aljedai, A., & AlSudais, H. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155324 · Cited by 3
Interactive and combined effects of body roundness index and triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio on diabetes mellitus and the mediating effects of TG/HDL-C in middle-aged and elderly adults: A nationwide prospective cohort study
Xu, L., Ma, J., Li, D., Yang, X., Wang, X., Liu, J., & Xu, Y. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112980 · Cited by 2
EVALUATION OF SERUM IRISIN WITH LIPID PROFILE IN TYPE-2 DIABETIC PATIENTS IN SULAIMANI
Maarouf, F. B., Mohammed, M., Omer, N. A., & Nore, B. F. (2018) · Journal of Sulaimani Medical College · doi:10.17656/jsmc.10160 · Cited by 2
NUTRITIONAL AND PHYSICAL-FITNESS FACTORS COURSING WITH NON-COMMUNICABLE DISEASES FROM OVERWEIGHT TO A HIGHER RISK OF VASCULAR AND LIVER OUTCOMES IN A COMMUNITY-BASED ADULTS
Kano, H. T., Burini, F. H., & Burini, R. C. (2022) · International Journal of Health Science · doi:10.22533/at.ed.1592162216033 · Cited by 3
Correlation between HbA1c and Triglyceride Level with Coronary Stenosis Degree in Type 2 Diabetes Mellitus with Coronary Heart Disease
Adninta, L., Samsuria, I. K., & Limijadi, E. K. S. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.8859 · Cited by 3
Antidiabetic agents: Do they hit the right targets?
Zhao, Y., Zhang, X., Liang, H., & Wang, L. (2022) · Frigid Zone Medicine · doi:10.2478/fzm-2022-0030 · Cited by 2
Remnant Indices for Estimating Postprandial Lipidemia in Young Women
Mizutani, E., & Naito, M. (2023) · International Journal of Nutrition and Food Sciences · doi:10.11648/j.ijnfs.20231201.13 · Cited by 2
Lipoprotein Metabolism and Alterations Induced by Insulin Resistance and Diabetes
TOMKIN, G. H., & Owens, D. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_5 · Cited by 3
NAD Pathways in Diabetic Coronary Heart Disease: Unveiling the Key Players
Liu, Y., Zhan, W., Wang, L., & Wang, W. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673293982240221050207 · Cited by 2
The effect of electron beam on oxidative stress and inflammatory factors in diabetes mellitus: An in vitro and in vivo study
Martirosyan, D. M., Shahnazari-Aval, M., Ashoori, M. R., Mikaeili, A. S., Nakhjavani, M., & Mirmiranpour, H. (2021) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v11i7.803 · Cited by 2
[Preliminary analysis of the relationship between peripheral arterial disease and other atherosclerosis markers and diabetic nephropathy].
Rioja, J., Moreno, T., Coca, I., Jiménez-Villodres, M., Rodríguez-Morata, A., & Valdivielso, P. (2014) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2014.02.004 · Cited by 2
Response to a Long-term High-Fat Diet in the Signature of Genes Involved in Lipid Metabolism in ApoE−/− Mice
Yang, M., Li, S., Yang, G., Li, L., & Liu, H. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182688026 · Cited by 2
Studies of association of AGPAT6variants with type 2 diabetes and related metabolic phenotypes in 12,068 Danes
Snogdal, L. S., Grarup, N., Banasik, K., Wod, M., Jørgensen, T., Witte, D. R., Lauritzen, T., Nielsen, A. A., Brandslund, I., Christensen, C., et al. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-113 · Cited by 2
Isolated hyperglycaemia does not increase VLDL-triacylglycerol secretion in type 1 diabetic men
Johansen, R. F., Søndergaard, E., Sørensen, L. P., Nellemann, B., Christiansen, J. S., & Nielsen, S. (2014) · Diabetologia · doi:10.1007/s00125-014-3422-6 · Cited by 2
Can Metric Parameter Combining Metabolic Syndrome Components Usefully Predict Coronary Artery Disease?
Youssef, S. M. (2013) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000119 · Cited by 2
Remodelling Metabolic Syndrome Components to Adapt them to the Tunisian Context and to Determine a Sole Metric Criterion
Youssef, S. M. (2013) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000121 · Cited by 2
Transgenic Rodents with Altered SSAT Expression as Models of Pancreatitis and Altered Glucose and Lipid Metabolism
Uimari, A., Hyvönen, M. T., Pirinen, E., & Alhonen, L. I. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-034-8_8 · Cited by 2
Oxidative Stress in Type 1 Diabetes Mellitus: Ethnic Aspects
Kolesnikova, L. I., Darenskaya, M. A., Grebenkina, L., Gnusina, S. V., & Kolesnikov, S. I. (2018) · InTech eBooks · doi:10.5772/intechopen.76512 · Cited by 2
Updated management of dyslipidaemia in diabetes: A new step towards more stringent targets
Monnier, L., Schlienger, J.-L., & Colette, C. (2021) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2021.100001 · Cited by 2
Insulin Resistance and Coronary Heart Disease
Laakso, M., & Kuusisto, J. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50023-1 · Cited by 2
Gender based variation of lipid abnormalities in type-2 diabetes mellitus patients
Jaidev, A., Shah, H., Andrews, L., & Vagheda, B. N. (2021) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20213934 · Cited by 2
ATP-Binding Cassette Protein ABCC10 Deficiency Prevents Diet-Induced Obesity but Not Atherosclerosis in Mice
Otaibi, A. A., Mubarak, S. A. S., Qarni, A. A. A., Hawwari, A., Bakillah, A., & Iqbal, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213813 · Cited by 2
Transcription factor 7-like 2 (TCF7L2) Gene Polymorphism rs7903146 is Associated with Lipid Profile and Risk of Cardiovascular Disease in Metabolic Syndrome Subjects
Rezaei, M., Palizban, A., Zamani-Doabi, S., & Shojaee, M. (2016) · Journal of Biology and Today s World · doi:10.15412/j.jbtw.01050703 · Cited by 2
Effect of aqueous extract of Clerodendrum thomsoniae Linn. leaves on the onset of hyperlipidaemia and the inhibition of gain mass on wistar rats
Martial, D. N. E., Dimitry, M. Y., Dongmo, F., Patrick, Y., Selestin, S. D., & Njintang, N. Y. (2021) · Asian Journal of Pharmacy and Pharmacology · doi:10.31024/ajpp.2021.7.6.2 · Cited by 2
Biochemical effect of ezetimibe/ simvastatin and ginger root extract on hyperlipidemia and diabetes mellitus induced experimentally in rats
elhamid, O. A., Abd-Elsamad, N., & El-Shawarby, R. M. (2015) · Benha Veterinary Medical Journal · doi:10.21608/bvmj.2015.32539 · Cited by 1
Recommandations récentes dans les dyslipidémies du diabétique : commentaire à partir de trois cas cliniques
Monnier, L., Schlienger, J.-L., & Colette, C. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.02.015 · Cited by 1
Dislipidemia Aterogenik pada Pasien Diabetes Melitus Tipe 2: Patofisiologi dan Pilihan Terapi
Rosandi, R. (2021) · MEDICINUS · doi:10.56951/medicinus.v34i1.47 · Cited by 3
Old and Novel Predictors for Cardiovascular Risk in Diabetic Foot Syndrome—A Narrative Review
Adam, C. A., Marcu, D. T. M., Mitu, O., Roca, M., Aursulesei, V. O., Zabara, M., Tribus, L. C., Cumpăt, C. M., Crișan-Dabija, R. A., & Mitu, F. (2023) · Applied Sciences · doi:10.3390/app13105990 · Cited by 1
Assessment of Lipid Profile and Clinical Manifestation of Obese Patients with Type 2 Diabetes
Taresh, A. I. (2024) · European Journal of Medical and Health Research · doi:10.59324/ejmhr.2024.2(4).14 · Cited by 1
Pathophysiology Mechanism in Therapeutics of Metabolic Syndrome
Singh, N. K., Dubey, P., Singh, S., & Singh, R. (2025) · Springer eBooks · doi:10.1007/978-981-95-3746-4_2 · Cited by 1
Duration-dependent alterations of lipid profiles and microvascular complications in GCK-MODY
Huang, Y., Fan, Y., Liu, X., Liu, X., Li, W., Yang, Y., Zhang, Z., Ma, S., Ji, S., Chen, S., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168137 · Cited by 1
From discarded by-product to functional bioactive: Date seed extracts reverse pancreatic β-cell dysfunction via multi-pathway regulation in diabetic rats
Batool, F., Hussain, G., Irfan, S., & Iftikhar, A. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107228 · Cited by 1
High-density lipoprotein cholesterol: function, dysfunction, and clinical implications
Trabanino, S., Rodríguez, A., & Rodríguez, F. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101672 · Cited by 1
Association Between the Triglyceride-to-HDL Cholesterol Ratio and Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Real-World Retrospective Study
Erol, A., & Şahin, M. F. (2026) · Biomedicines · doi:10.3390/biomedicines14091995 · Cited by 1
Neues zur Pathobiochemie der diabetischen Dyslipidämie
Schwarz, F., Roden, M., & Müssig, K. (2012) · Der Diabetologe · doi:10.1007/s11428-012-0888-z · Cited by 1
Effects of Metabolic Syndrome on Atherosclerosis in Childhood
Qureshi, M. Y., Messiah, S. E., Miller, T. L., & Lipshultz, S. E. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2366-8_5 · Cited by 1
Gender Variation of Lipid Profiles of Type-2 Diabetes Mellitus Patients attended at a Specialized Diabetic Hospital in Dhaka
Yeasmin, R., Nahar, N., Muttalib, M., Bhuiyan, M. N. H., Zahid, A. Z. R., & Jahan, W. A. (2015) · Journal of Current and Advance Medical Research · doi:10.3329/jcamr.v2i2.24876 · Cited by 2
The metabolic syndrome--new and old data.
Pîrcălăboiu, L., Popa, S. G., Puiu, I., Dinu, R., Dinu, F., & Moţa, M. (2010) · PubMed · Cited by 1
Special Patient Populations: Diabetes and Metabolic Syndrome
Kurra, S., Chahil, T. J., & Ginsberg, H. N. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50041-x · Cited by 1
Physiologic changes in obesity and patient preparation for bariatric surgery
Şahin, T. T. (2017) · Laparoscopic Endoscopic Surgical Science · doi:10.14744/less.2014.33042 · Cited by 1
Double diabetes: the cardiovascular implications of combining type 1 with type 2 diabetes
Cleland, S. (2017) · Practical Diabetes · doi:10.1002/pdi.2120 · Cited by 1
Avant-propos Ars longa… iudicium difficile. L’exemple des recommandations dans les dyslipidémies du diabétique
Monnier, L., Colette, C., Azrak, A. E., Rochd, D., Essekkat, N., & Bakri, A. M. N. (2018) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30055-5 · Cited by 1
Comparative study of efficacy and safety of omega 3 fatty acids and fenofibrate with background atorvastatin therapy in patients of atherogenic dyslipidaemia
Arora, A. V., Singh, N. R., & Sharma, R. (2019) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20192176 · Cited by 1
Apolipoprotein A-I Stimulates Secretion of Insulin and Matrix Metalloproteinases by Islets of Langerhans
Федорович, У. И., Poteryaeva, O. N., Русских, Г. С., Zubova, A., Boiko, K. Y., & Polyakov, L. M. (2018) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750818040091 · Cited by 1
Lipids and Lipoproteins as Biomarkers of Vascular Complications in Diabetes and Their Modulation by Dietary Phytochemicals
Basu, A., Basu, P., Morris, S., & Lyons, T. J. (2016) · Springer eBooks · doi:10.1007/978-94-007-7678-4_49 · Cited by 1
TG/HDL, Non-HDL, and TyG index as predictive parameters for CVDs in uncontrolled diabetic patients better than LDL-C and LDL/HDL ratio
Alshawi, A., & Alnaji, H. A. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00926 · Cited by 1
Production and Metabolism of Triglyceride-Rich Lipoproteins: Impact of Diabetes
Pirillo, A., Norata, G. D., & Catapano, A. L. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_7 · Cited by 3
Special Patient Populations
Reyes‐Soffer, G., & Ginsberg, H. N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00035-9 · Cited by 1
Study the Effects of Annona sp. Extract on Some Physiological Parameters and Fertility in Diabetic Mice
Ibraheem, S. R., Ahmed, E. S., Mahmoud, Z. F., & Al-Bari, H. I. A. (2024) · Iraqi Journal of Science · doi:10.24996/ijs.2024.65.6.6 · Cited by 1
Insulin Resistance and Its Biochemical Basis in Metabolic Syndrome
Hasnani, D., Iglesias-Fortes, S., Lockwood, Á. C., & Chavda, V. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-75686-3_2 · Cited by 2
Dyslipidemia in the Metabolic Syndrome
Hanefeld, M., & Schäper, F. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50021-8 · Cited by 1
Disrupted VLDL Features and Lipoprotein Metabolism in Sepsis
Aspichueta, P., Bartolom, N., Buqu, X., Jos, M., Ochoa, B., & Chico, Y. (2012) · InTech eBooks · doi:10.5772/29421 · Cited by 1
Lipid Droplets and Very Low Density Lipoproteins; Their Relation to Insulin Resistance
Olofsson, S., Andersson, L. K., Perman, J., Rutberg, M., Haversen, L., Lu, L., Lu, E., Mobini, R., Ståhlman, M., Myhre, S., et al. (2011) · InTech eBooks · doi:10.5772/21559 · Cited by 1
Contribución de la apolipoproteína CIII a la aterogenicidad de las dislipidemias
Camejo, G., & Davidsson, P. (2012) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2012.02.006 · Cited by 1
Effect of hyperglycemia on LDL oxidation in type 2 diabetic patients
Singh, N., Singh, N., Singh, S., Agarwal, N., & Kafle, D. (2012) · Journal of Medical Nutrition and Nutraceuticals · doi:10.4103/2278-019x.101302 · Cited by 1
Lipoproteins and Diabetic Nephropathy
Mäkinen, V., Tolonen, N., & Groop, P. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_14 · Cited by 1
Understanding the types and causes of diabetes mellitus
Wanjiru, J. M. (2018) · Cited by 1

Authors: Taskinen, M.-R.
Affiliations: University of Helsinki (FI)
Corresponding author: Taskinen, M.-R.
ORCID: Taskinen, M.-R.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2003-06-01
Volume: 46
Issue: 6
Pages: 733-749
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-003-1111-y
OpenAlex: W2020659754
Cited by: 888
References: 183
Citations by year: 2026: 27 · 2025: 37 · 2024: 32 · 2023: 36 · 2022: 48 · 2021: 41 · 2020: 39 · 2019: 27 · 2018: 32 · 2017: 28 · 2016: 29 · 2015: 47 · 2014: 41 · 2013: 46 · 2012: 42
FWCI: 6.10
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Funders: Helsingin ja Uudenmaan Sairaanhoitopiiri
Academy of Finland
Diabetesliitto
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: diabetic dyslipidemia, type 2 diabetes, small dense LDL, triglyceride-rich lipoproteins, VLDL assembly, hepatic lipid metabolism, insulin signaling, PI3-kinase, SREBP-1c, de novo lipogenesis, apolipoprotein B-100, peroxisome proliferator-activated receptors, SREBP1, liver X receptor
MeSH terms: Diabetes Mellitus, Diabetes Mellitus, Type 2, Humans, Hyperlipidemias, Lipoproteins, Lipoproteins, VLDL, Diabetes Complications, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetic dyslipidaemia: from basic research to clinical practice*

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks